デフォルト表紙
市場調査レポート
商品コード
1610858

デジタル糖尿病管理の市場規模、シェア、成長分析、製品・サービス別、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年

Digital Diabetes Management Market Size, Share, Growth Analysis, By Product & Service, By Type, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 174 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタル糖尿病管理の市場規模、シェア、成長分析、製品・サービス別、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年
出版日: 2024年12月07日
発行: SkyQuest
ページ情報: 英文 174 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタル糖尿病管理の世界市場規模は2022年に172億米ドルとなり、予測期間(2024-2031年)のCAGRは13.70%で、2023年の195億6,000万米ドルから2031年には546億2,000万米ドルに成長する見通しです。

デジタル糖尿病管理市場は、技術の進歩と糖尿病有病率の上昇によって大きな成長を遂げています。国際糖尿病連合は、成人の糖尿病患者数が2021年の5億3,700万人から2045年には7億8,300万人に増加すると予測しています。この急増は、喫煙、飲酒、肥満などのライフスタイルの変化と密接に関連しており、後者は糖尿病患者の主な原因となっています。患者の血糖値モニタリングを支援するウェブベースのアプリケーションが100種類以上提供されている中、スマートフォンアプリの採用が急増しています。糖尿病管理に対する意識が向上し、肥満人口が増加するにつれて、ダイエット・体重管理アプリケーションの市場は繁栄し、患者のケアと治療成績の向上を目指したデジタル・エコシステムが育成されると予想されます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • ケーススタディ

デジタル糖尿病管理の市場規模:製品・サービス別& CAGR(2024-2031)

  • 市場概要
  • デバイス
    • スマート血糖値測定器
    • 持続血糖モニタリングシステム
    • スマートインスリンペン
    • スマートインスリンポンプ/クローズドループシステムとスマートインスリンパッチ
  • デジタル糖尿病管理アプリ
    • 糖尿病と血糖値追跡アプリ
    • 体重とダイエット管理アプリ
  • データ管理ソフトウェアとプラットフォーム
  • サービス

デジタル糖尿病管理の市場規模:タイプ別& CAGR(2024-2031)

  • 市場概要
  • ウェアラブルデバイス
  • ハンドヘルドデバイス

デジタル糖尿病管理の市場規模:エンドユーザー別& CAGR(2024-2031)

  • 市場概要
  • セルフ/在宅ヘルスケア
  • 病院と糖尿病専門クリニック
  • 学術研究機関

デジタル糖尿病管理の市場規模:地域別& CAGR(2024-2031)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Medtronic
  • F. Hoffmann-La Roche
  • Dexcom, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Tidepool
  • Glooko, Inc.
  • LifeScan, Inc.
  • AgaMatrix
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • DarioHealth Corporation
  • One Drop
  • Ypsomed Holding AG
  • Arkray
  • Dottli
  • Acon Laboratories, Inc.
  • Care Innovations, LLC
  • Health2Sync

結論と推奨事項

目次
Product Code: SQMIG45E2282

Global Digital Diabetes Management Market size was valued at USD 17.20 billion in 2022 and is poised to grow from USD 19.56 billion in 2023 to USD 54.62 billion by 2031, growing at a CAGR of 13.70% during the forecast period (2024-2031).

The digital diabetes management market is experiencing significant growth driven by technological advancements and the rising prevalence of diabetes. The International Diabetes Federation projects that the number of adults with diabetes will rise from 537 million in 2021 to 783 million by 2045. This surge is closely linked to changing lifestyles, including increased rates of smoking, alcohol consumption, and obesity, the latter being a key contributor to diabetes cases. With over a hundred web-based applications available to assist patients in monitoring blood glucose levels, the adoption of smartphone apps has skyrocketed. As awareness around diabetes management improves and the obese population grows, the market for diet and weight control applications is expected to flourish, fostering a digital ecosystem aimed at enhancing patient care and outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Diabetes Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Diabetes Management Market Segmental Analysis

Global Digital Diabetes Management Market is segmented by Product & Service, Type, End User, and region. Based on Product & Service, the market is segmented into Devices, Digital Diabetes Management Apps, Data Management Software and Platforms, and Services. Based on Type, the market is segmented into Wearable Devices, and Handheld Devices. Based on End User, the market is segmented into Self/Home Healthcare, Hospitals and Specialty Diabetes Clinics, Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Digital Diabetes Management Market

The Global Digital Diabetes Management market is primarily driven by heightened health concerns among the public. As awareness regarding diabetes and its complications continues to rise, there is an escalating demand for digital management systems. Health promotion campaigns and educational initiatives have effectively informed individuals about the importance of proactive health management and self-monitoring. This growing recognition of effective diabetes care has led to an increased interest in digital platforms that offer easy access to valuable resources and tools. Consequently, the market is witnessing a surge in the adoption of digital solutions aimed at improving diabetes management.

Restraints in the Global Digital Diabetes Management Market

One significant restraint facing the Global Digital Diabetes Management market is the challenge of varying levels of technical literacy among patients. Many individuals, particularly older adults or those with limited technological skills, struggle to navigate complex applications and devices, leading to a reluctance to adopt digital solutions for diabetes care. This reluctance hinders the full utilization of these technologies, which are designed to enhance patient management and outcomes. To address this issue, it is crucial to prioritize the development of user-friendly products and provide comprehensive training, ensuring that all patients, regardless of their comfort level with technology, can effectively engage with and benefit from digital diabetes management solutions.

Market Trends of the Global Digital Diabetes Management Market

The Global Digital Diabetes Management market is witnessing a significant trend towards AI-powered personalized care, revolutionizing diabetes treatment protocols. By leveraging advanced algorithms, healthcare providers can now analyze extensive patient data to tailor individualized regimens for medication, diet, and exercise. This personalized approach not only enhances patient engagement but also fosters a proactive attitude towards diabetes management, encouraging higher compliance rates and improved health outcomes. As patients receive customized insights and actionable recommendations, the demand for digital health solutions is surging, signaling a transformative shift in how diabetes care is delivered on a global scale, ultimately aiming for better patient results and quality of life.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Digital Diabetes Management Market Size by Product & Service & CAGR (2024-2031)

  • Market Overview
  • Devices
    • Smart Glucose Meters
    • Continuous Glucose Monitoring Systems
    • Smart Insulin Pens
    • Smart Insulin Pumps/Closed-loop Systems And Smart Insulin Patches
  • Digital Diabetes Management Apps
    • Diabetes And Blood Glucose Tracking Apps
    • Weight And Diet Management Apps
  • Data Management Software and Platforms
  • Services

Global Digital Diabetes Management Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Wearable Devices
  • Handheld Devices

Global Digital Diabetes Management Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Self/Home Healthcare
  • Hospitals And Specialty Diabetes Clinics
  • Academic And Research Institutes

Global Digital Diabetes Management Market Size & CAGR (2024-2031)

  • North America, (Product & Service, Type, End User)
    • US
    • Canada
  • Europe, (Product & Service, Type, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product & Service, Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product & Service, Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product & Service, Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care Holdings AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tidepool
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glooko, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeScan, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AgaMatrix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tandem Diabetes Care, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DarioHealth Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • One Drop
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arkray
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dottli
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acon Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Care Innovations, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Health2Sync
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation